The Official Comment of AHRMM to the United States Department of Health and Human Services Food and Drug Administration (FDA) regarding Unique Device Identification for Medical Devices Docket No. FDA-2011-N-0090
AHRMM comments to the FDA regarding an amendment to the UDI proposed rule to address the UDI implementation time frame required by the 2012 Food and Drug Administration Safety and Innovation Act (FDASIA).
Related Resources
Guides/Reports
The AHRMM Cost, Quality, and Outcomes (CQO) Movement was launched in 2013 to advance the role of the health care supply chain in delivering b
Webcast
Lisa Fohey, director of supply chain, Children’s Hospital of Wisconsin, leads an overview of the main principals of project management and change
Webcast
Lisa Fohey, director of supply chain, Children’s Hospital of Wisconsin, explores the principles of project management and change management t
White Papers
In an effort to capture broader insights on UDI adoption from across the health care field, AHRMM, with participation by the FDA, held LUC Dat
Webcast
Explore the new delivery methods of health care, how community resources and organizations are now working together to reduce patient episodic